Cost-Effectiveness of Disease- Modifying Therapies in Multiple Sclerosis: A Managed Care Perspective
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
3
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
4
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
5